大參林(603233.SH)擬1.27億元收購南通江海大藥房51%的股權
格隆匯11月6日丨大參林(603233.SH)公佈，公司與交易方鼎俊管理、惠惠管理簽訂了《股權轉讓協議》，擬收購其持有南通市江海大藥房連鎖有限公司(“南通江海大藥房”或“目標公司”)51%的股權，目標公司包含123家連鎖藥店，收購金額約1.27億元。
“南通江海大藥房”是南通市藥品零售銷售規模和品牌影響力名列前茅的地方龍頭企業之一，門店在南通市場已持續經營11年，2014年4月，註冊成立連鎖公司，將門店進行連鎖化經營管理，現有直營門店123家(已開業門店113家，未開業門店10家)，其中醫保門店86家，分佈在南通市區及周邊縣城區域，門店佈局合理且具有戰略意義，為後期連鎖藥店的豐滿佈局打下堅實的基礎；“南通江海大藥房”門店全部為租賃物業，總租賃面積1.63萬平方米(含門店、總部及配送中心)，店鋪租賃關係穩定，可確保門店持續經營。該公司門店具有單店產出較高、陳列布局合理、顧客忠誠度高、藥店專業氛圍濃厚等特點，以及良好的市場聲譽和發展前景。
此次收購約定2019年度為考察期。轉讓方承諾目標公司2019年度含税年銷售額不低於22000萬元，經審計扣非淨利潤不低於1200萬元。如目標公司考察期間的年銷售、毛利率、淨利潤額任一指標不達標，則受讓方有權按照不達標比例調整估值並相應調減轉讓款。如出現多項指標不達標的，則取調減金額最高者進行調減轉讓款。
目標公司下屬有123間零售藥店，位於江蘇省南通市，是當地藥品零售銷售規模和品牌影響力名列前茅的地方龍頭企業。門店經營質量優良，在2018年-2019年快速拓展新店的同時老店仍保持較高的平均單店產出，市場仍有較大的發展空間。合作後將共享“大參林”採購平台通過降低商品採購成本、加強門店專業水平及標準化、提升門店賣場及招牌等整體形象、優化區域消費品類及代理品種等措施，不斷提升銷售和毛利率水平，從而擴大公司品牌影響力。
此次收購，符合公司“深耕華南，佈局全國”的擴張戰略理念；有助於公司加固拓展市場，有利於公司以南通市及“南通江海大藥房”為長三角經濟帶樞紐，加速對南通市及周邊區域的擴張。南通市為長江北岸經濟帶“長江三角洲”洲頭城市，具有先天的地理優勢，是江蘇省的重要經濟區域，有利於擴大公司品牌影響力，進一步打造優勢區域。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
